| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V73513 | ABC34 | 1831135-56-8 | ABC34 is the inactive control compound of JJH260. |
|
V3834 | ABX-1431 | 1446817-84-0 | ABX-1431 is a highly potent, selective, covalent, irreversible, and orally bioavailable, CNS-penetrant MGLL (serine hydrolase monoacylglycerol lipase) inhibitor that has potential use in the treatment of neurological disorders. |
|
V87588 | JW 618 | 1416133-88-4 | JW 618 is a selective ABHD6 inhibitor with IC50 of 38 and 13 nM for mouse and rat ABHD6, respectively. |
|
V1949 | JZL184 | 1101854-58-3 | JZL 184 is the first potent, irreversible and selective inhibitor of monoacylglycerol lipase (MAGL) with IC50 of 8 NM. |
|
V87592 | MAGL-IN-15 | 2770967-08-1 | MAGL-IN-15 (Compound 6) is a MAGL inhibitor that can be used to study diseases and conditions related to the modulation of endocannabinoid system signaling activity. |
|
V139284 | MAGL-IN-21 | MAGL-IN-21 is a selective inhibitor of monoacylglycerol lipase (MAGL) with an IC50 of 1.59 nM. | |
|
V73515 | MAGL-IN-4 | 2135785-20-3 | MAGL-IN-4 is an orally bioactive, selective and reversible inhibitor of monoacylglycerol lipase (MAGL) with IC50 of 6.2 nM. |
|
V78909 | MAGL-IN-8 | 3017151-71-9 | MAGL-IN-8 (compound 13) is a reversible inhibitor of monoacylglycerol lipase (MAGL) with IC50 of 2.5 ± 0.4 nM for hMAGL. |